EP1032702A1 - Reagents and methods for detecting genes related to major histocompatibility complex of domestic fowl, such as chicken - Google Patents
Reagents and methods for detecting genes related to major histocompatibility complex of domestic fowl, such as chickenInfo
- Publication number
- EP1032702A1 EP1032702A1 EP98955723A EP98955723A EP1032702A1 EP 1032702 A1 EP1032702 A1 EP 1032702A1 EP 98955723 A EP98955723 A EP 98955723A EP 98955723 A EP98955723 A EP 98955723A EP 1032702 A1 EP1032702 A1 EP 1032702A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nucleic acid
- gene
- chicken
- genes
- rfp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- the invention relates to the detection of genes linked to the major histocompatibility complex (MHC) of farmed birds, such as chicken.
- MHC major histocompatibility complex
- the invention also relates to the applications of these nucleic acid molecules, in particular for the development of genotyping tests in farmed birds, in particular chicken, and for the selection of animals of interest.
- Vaccination was an effective prophylaxis until the emergence of hypervirulent strains, making it necessary to identify resistant haplotypes.
- the work of the inventors on the sequencing of genes of the MHC showed the genetic complexity of this region, which led them to take into account another type of polymorphism, namely based on the sequence of these genes and related regions, such than those of their promoters and of microsatellite regions.
- the inventors have thus developed means for obtaining oligonucleotide molecules highly specific for the polymorphisms observed, making it possible to identify the parts of genes, and even the sites involved in controlling the resistance or the susceptibility to the development of tumors.
- the object of the invention is therefore to provide nucleic acid molecules making it possible to specifically detect, in farmed birds and in particular in chicken, the genes linked to MHC involved in the phenomena of resistance or susceptibility to the development of viral-induced tumors. It also aims to provide a method and a kit for the detection of genotypes for easy routine implementation.
- the nucleic acid molecules of the invention are characterized in that they are molecules, isolated from their natural environment, of nucleic acids of genes coding for proteins involved in the control of resistance or susceptibility to the development of viral-induced tumors in farmed birds, such as those of Marek's disease in chicken, with, where appropriate, the regions attached to them, such as those of the promoter or of microsatellites.
- the term gene as used in the description and claims encompasses these regions.
- nucleic acid molecules are more particularly characterized in that they present the nucleic acid sequences of genes of the B system or of the Rfp-Y system of the MHC of farmed birds, with the exception of the sequences of the genes of class II BL, of the gene 17.5, of the gene 12.3 and of the gene B-IVF of class I, or are capable of pairing with one of the strands of a gene capable of coding for a protein as defined above under weakly stringent conditions.
- the pairing under low stringency conditions referred to above is carried out at room temperature, in a 0.1 SSC medium, with washing at room temperature.
- Class II BL genes are described in I munogenetics 31: 179-187, 1990 and Eur. J. Immunol, 1993, 23: 1139-1145.
- Gene 17.5 belongs to the superfamily of genes coding for lectins and gene 12.3 to the family of genes coding for guanine-binding proteins (guanine nucleotide-binding protein). This gene is described in Immunogenetics 39: 221-229, 1994.
- the class I B-IVF gene is described in Immunogenetics 31: 405-409, 1990.
- the invention relates in particular to nucleic acid molecules corresponding to those of the sequences of one of the following genes:
- nucleic acid sequences of the molecules defined above has made it possible to pinpoint the blocks of polymorphisms which must be detected in order to establish a reliable and precise genotyping. By comparing the sequences of these blocks, originating from different genes of the same haplotype or from the same gene of different haplotypes, the inventors took into account the divergent sequences and developed, for each gene, oligonucleotides complementary to these divergent sequences. .
- the invention relates especially to the molecules of oligonucleotides corresponding to these sequences and comprising a part of the polymorphic region of the MHC systems of chicken or other farmed birds.
- the polymorphic region may be in the gene or in a related region such as the microsatellite regions or that of the promoter.
- the polymorphisms are linked to the function of the MHC systems. It is thus advantageously molecules corresponding to a part of an exon.
- molecules corresponding to exon 2 (domain ⁇ 1) of the chicken's YF genes are linked to molecules corresponding to exon 2 (domain ⁇ 1) of the chicken's YF genes.
- a suitable pair of primers consists of:
- the oligonucleotide molecules correspond to a part of a polymorphic region which is not linked to the function of the MHC systems. Preferred regions of this type are microsatellites.
- oligonucleotide molecules which can be used to form primer pairs correspond to the following sequences: B-FI: 5 'CCA GCA GTC ACT GCA CAT AT 3'
- oligonucleotide molecules defined above and those developed from known genes, but according to the approach of the invention, highly specific sets of primers are available, making it possible to precisely determine the haplotype of the animal to be studied and to detect whether it is resistant to the development of viral-induced tumors, or on the contrary capable of being affected.
- the invention therefore also relates to a method of genotyping farmed birds and in particular chicken.
- This method is characterized in that it comprises the amplification of a sample of nucleic acid originating from the animal to be studied using one or more pairs of primers capable of hybridizing specifically with the nucleic acid of a polymorphic region of the Rfp-Y or B systems of the MHC of said birds, and
- the nucleic acid sample consists in particular of genomic DNA extracted from biological material of the animal to be studied or by this material itself, in particular from the blood of the animal. It may alternatively be cDNA, RNA or even PNA (polypeptides nucleic acids).
- the primers are produced from the oligonucleotide molecules defined above and, in general, from any gene (and related region) coding for a protein involved in the control of the resistance or the susceptibility to viral-induced tumors in farmed birds and in particular chicken, in particular the BL genes of class II, 17.5, 12.3 and B-FIV of class I.
- primers of microsatellite regions making it possible to detect haplotypes of the B complex, such as those produced from the B-FI gene, and mentioned above, or primers making it possible to detect haplotypes of the system.
- RFp-Y and developed from the 17.5 gene, like the couple:
- PCR detection is carried out according to conventional techniques. These techniques include sequencing, electrophoresis, hybridizations with SSOP or SSCP analysis.
- PCR products will be advantageously detected according to their size by using electrophoresis techniques.
- hybridization techniques will be used more specifically for the purpose of differentiating haplotypes of PCR products (analysis on a membrane using probes specific for 'haplotypes, SSOP or Sequence Specifies Oligonucleotide Probe), differential migration of denatured samples (SSCP or Single Strand Conformational Polymorphism), or sequencing. In general, the latter technique is preferred given the simplicity of its implementation.
- the invention thus provides a simple and rapid technique for establishing the genetic profile of a large number of animals to be studied, which makes it possible to determine the haplotypes and to select those of interest with a view to breeding.
- the invention also relates to a box or kit for detecting the genotype of the chicken or other farmed bird according to the method defined above.
- boxes or kits are characterized in that they contain the reagents necessary for carrying out at least one PCR and the revelation test.
- they include the primers for the PCR, a positive control for the reaction, as well as instructions for use.
- the primers are in lyophilized form or in solution or, depending on the method of detection, on a support.
- the support can be, in a conventional manner, a multiwell plate or be in the form of DNA chips.
- the invention further relates to an experimental system which makes it possible to study the resistance to tumor development in chicken.
- FIG. 9 representing a photo of electrophoresis of PCR products illustrating the genotyping test of the invention. It will be recalled that FIGS. 1 to 8, already mentioned above, illustrate the gene sequences according to the invention.
- Genomic DNA 1 ⁇ g Oligos take: 0.3 ⁇ M dNTP: 8 ⁇ l qs H 2 0 50 ⁇ l 50 ⁇ l of Mix 2 is added by mixing,
- Genomic DNA 1 ⁇ g
- Oligos take: 0.3 ⁇ M dNTP: 8 ⁇ l qs H 2 0 50 ⁇ l and add 50 ⁇ l of Mix 2 by mixing.
- the test was applied to 9 chicken haplotypes, serologically selected for complex B.
- FIG. 9 gives a photo of electrophoresis on agarose gel at 1% of the PCR products obtained at the end of the amplification step.
- Lanes 1 and 27 correspond to the size markers and lanes (2 to 25) to the PCR products of the following haplotypes: lane 2: B4; lane 4: B5; lane 5: B7; tracks 6 to 11: B12; tracks 12, 13, 14: B13; tracks 15, 16, 17, 18: B14; lane 19: B15; tracks 20, 21, 23, 24; B21; track 25: BX (no detection for tracks 3 and 22).
- Examination of this figure shows that individuals who have the B12 haplotype give the same band and are therefore very homogeneous. The same observation applies to individuals B14.
- B21 we see that the profiles are different, which demonstrates the ineffectiveness of the serological approach. Given the position of the BX band, it is determined that it is a B4 haplotype.
- the invention thus provides the means to verify the homogeneity of the animals and to carry out rigorous selections by taking into account each system of the MHC, and in these systems the genes sought.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention concerns nucleic acid molecules for detecting the MHC genes involved in phenomena of resistance or proneness to the development of virus-induced tumours. The primers prepared from said molecules can be used in a method for genotyping domestic fowl, characterised in that it consists in: amplifying a nucleic acid sample derived from the animal under study using one or several pairs of primers capable of being specifically hybridised with the nucleic acid of a pleomorphic region of the Rfp-Y or B systems of the MHC of said fowl; detecting the resulting PCR products.
Description
REACTIFS ET METHODES POUR LA DETECTION DE GENES LIES AU COMPLEXE MAJEUR D 'HISTOCOMPATIBILITE D'OISEAUX D'ELEVAGE, TELS QUE LE POULET REAGENTS AND METHODS FOR THE DETECTION OF GENES RELATED TO THE MAJOR COMPLEX OF HISTOCOMPATIBILITY OF BREEDING BIRDS, SUCH AS CHICKEN
L'invention a pour objet la détection de gènes liés au complexe majeur d'histocompatibilité (CMH) d'oiseaux d'élevage, tels que le poulet. A ce titre, elle concerne des molécules d'acides nucléiques permettant de détecter ceux des gènes du CMH impliqués dans les phénomènes de résistance ou de susceptibilité au développement de tumeurs viro-induites . L'invention concerne également les applications de ces molécules d'acides nucléiques, notamment pour le développement de tests de génotypage chez les oiseaux d'élevage, en particulier le poulet, et pour la sélection d'animaux d ' intérêt .The invention relates to the detection of genes linked to the major histocompatibility complex (MHC) of farmed birds, such as chicken. As such, it relates to nucleic acid molecules making it possible to detect those of the MHC genes involved in the phenomena of resistance or susceptibility to the development of viral-induced tumors. The invention also relates to the applications of these nucleic acid molecules, in particular for the development of genotyping tests in farmed birds, in particular chicken, and for the selection of animals of interest.
Les maladies virales infectieuses sont redoutées des éleveurs en raison de leur caractère contagieux qui conduit à des pertes importantes d ' animaux.Infectious viral diseases are feared by breeders because of their contagious nature which leads to significant losses of animals.
La vaccination a constitué une prophylaxie efficace jusqu'à l'émergence de souches hypervirulentes, rendant nécessaire 1 ' identification des haplotypes résistants.Vaccination was an effective prophylaxis until the emergence of hypervirulent strains, making it necessary to identify resistant haplotypes.
Diverses méthodes ont ainsi été proposées pour tenter de sélectionner ceux des animaux qui sont capables de résister à de telles pathologies et ceux qui sont au contraire susceptibles d'être affectés.Various methods have thus been proposed in an attempt to select those of the animals which are capable of resisting such pathologies and those which are on the contrary liable to be affected.
Les techniques les plus utilisées en routine sont basées sur des polymorphismes sérologiques ou de
type RFLP. Toutefois, ces méthodes ne fournissent pas de connaissances précises sur le phénomène de résistance ou de susceptibilité à la maladie, en particulier par manque de caractère discriminant vis-à-vis des gènes des systèmes B ou Rfp-Y du CMH.The most commonly used techniques are based on serological polymorphisms or RFLP type. However, these methods do not provide precise knowledge on the phenomenon of resistance or susceptibility to the disease, in particular by lack of discriminating character vis-à-vis the genes of the B or Rfp-Y systems of the MHC.
Les travaux des inventeurs sur le séquençage de gênes du CMH a montré la complexité génétique de cette région, ce qui les a conduits à prendre en compte un autre type de polymorphisme, à savoir basé sur la séquence de ces gènes et des régions apparentées, telles que celles de leurs promoteurs et des régions microsatellitaires . Les inventeurs ont ainsi mis au point des moyens pour disposer de molécules oligonucléotidiques hautement spécifiques des polymorphismes observés, permettant d'identifier les parties de gènes, et même les sites impliqués dans le contrôle de la résistance ou de la susceptibilité au développement de tumeurs.The work of the inventors on the sequencing of genes of the MHC showed the genetic complexity of this region, which led them to take into account another type of polymorphism, namely based on the sequence of these genes and related regions, such than those of their promoters and of microsatellite regions. The inventors have thus developed means for obtaining oligonucleotide molecules highly specific for the polymorphisms observed, making it possible to identify the parts of genes, and even the sites involved in controlling the resistance or the susceptibility to the development of tumors.
Le caractère spécifique de ces molécules, vis- à-vis d'un gène donné de l'un des systèmes du CMH, en fait des outils discriminants particulièrement fiables pour identifier avec précision la capacité de résistance ou de susceptibilité du poulet étudié, ou d'autres oiseaux, à une infection virale, et pour étudier au niveau moléculaire les séquences du CMH impliquées.The specific nature of these molecules, vis-à-vis a given gene from one of the MHC systems, makes them particularly reliable discriminating tools for precisely identifying the resistance or susceptibility capacity of the chicken studied, or d other birds, to viral infection, and to study at molecular level the MHC sequences involved.
L'invention a donc pour but de fournir des molécules d'acides nucléiques permettant de détecter spécifiquement, chez les oiseaux d'élevage et en particulier chez le poulet, les gènes liés au CMH impliqués dans les phénomènes de résistance ou de susceptibilité au développement de tumeurs viro- induites.
Elle vise également à fournir une méthode et un kit de détection de génotypes de mise en oeuvre aisée en routine .The object of the invention is therefore to provide nucleic acid molecules making it possible to specifically detect, in farmed birds and in particular in chicken, the genes linked to MHC involved in the phenomena of resistance or susceptibility to the development of viral-induced tumors. It also aims to provide a method and a kit for the detection of genotypes for easy routine implementation.
Les molécules d'acides nucléiques de l'invention sont caractérisées en ce qu'il s'agit de molécules, isolées de leur environnement naturel, d'acides nucléiques de gènes codant pour des protéines impliquées dans le contrôle de la résistance ou de la susceptibilité au développement de tumeurs viro-induites chez les oiseaux d'élevage, telles que celles de la maladie de Marek chez le poulet, avec le cas échéant, les régions qui leur sont attachées, telles que celles du promoteur ou microsatellitaires. Le terme gène tel qu'utilisé dans la description et les revendications englobe ces régions .The nucleic acid molecules of the invention are characterized in that they are molecules, isolated from their natural environment, of nucleic acids of genes coding for proteins involved in the control of resistance or susceptibility to the development of viral-induced tumors in farmed birds, such as those of Marek's disease in chicken, with, where appropriate, the regions attached to them, such as those of the promoter or of microsatellites. The term gene as used in the description and claims encompasses these regions.
Ces molécules d'acides nucléiques sont plus spécialement caractérisées en ce qu'elles présentent les séquences d'acides nucléiques de gènes du système B ou du système Rfp-Y du CMH des oiseaux d'élevage, à l'exception des séquences des gènes de classe II B-L, du gène 17.5, du gène 12.3 et du gène B-FIV de classe I, ou sont capables de s'apparier avec l'un des brins d'un gène capable de coder pour une protéine telle que définie ci- dessus dans des conditions faiblement stringentes.These nucleic acid molecules are more particularly characterized in that they present the nucleic acid sequences of genes of the B system or of the Rfp-Y system of the MHC of farmed birds, with the exception of the sequences of the genes of class II BL, of the gene 17.5, of the gene 12.3 and of the gene B-IVF of class I, or are capable of pairing with one of the strands of a gene capable of coding for a protein as defined above under weakly stringent conditions.
L ' appariement dans des conditions de faible stringence auquel il est fait référence ci-dessus est réalisé à température ambiante, dans un milieu 0,1 SSC, avec lavage à température ambiante.
Les gènes de classe II B-L sont décrits dans I munogenetics 31:179-187, 1990 et Eur. J. Immunol, 1993, 23:1139-1145.The pairing under low stringency conditions referred to above is carried out at room temperature, in a 0.1 SSC medium, with washing at room temperature. Class II BL genes are described in I munogenetics 31: 179-187, 1990 and Eur. J. Immunol, 1993, 23: 1139-1145.
Le gène 17.5 appartient à la superfamille des gènes codant pour les lectines et le gène 12.3 à la famille des gènes codant pour des protéines liant la guanine (guanine nucleotide-binding protein) . Ce gène est décrit dans Immunogenetics 39:221-229, 1994.Gene 17.5 belongs to the superfamily of genes coding for lectins and gene 12.3 to the family of genes coding for guanine-binding proteins (guanine nucleotide-binding protein). This gene is described in Immunogenetics 39: 221-229, 1994.
Le gène 12.3 est décrit dans P.N.A.S. USA, vol. 86, 4594-4598, juin 1989, Genetics.The 12.3 gene is described in P.N.A.S. USA, vol. 86, 4594-4598, June 1989, Genetics.
Le gène B-FIV de classe I est décrit dans Immunogenetics 31:405-409, 1990.The class I B-IVF gene is described in Immunogenetics 31: 405-409, 1990.
L'invention vise notamment les molécules d'acides nucléiques répondant à ceux des enchaînements de l'un des gènes suivants :The invention relates in particular to nucleic acid molecules corresponding to those of the sequences of one of the following genes:
enchaînement du système Rfp-YRfp-Y system chaining
B-FV (figure 1) , B-F VI (figure 2) ; . enchaînement du système B,B-FV (Figure 1), B-F VI (Figure 2); . sequence of system B,
8.4 génomique (figure 3) ; B-F I (figure 4) ; C12.1 (figure 5) ; DM (figure 6) ; TAPI (du début de l'exon 2 à l'extrémité 3') (figure 7) ; et TAP2G (figure8.4 genomics (Figure 3); B-F I (Figure 4); C12.1 (Figure 5); DM (Figure 6); TAPI (from the start of exon 2 to the 3 'end) (Figure 7); and TAP2G (figure
8) , et autres gènes compris dans la figure 10 et suites 1 à 35.8), and other genes included in FIG. 10 and suites 1 to 35.
L'étude des séquences d'acides nucléiques des molécules définies plus haut a permis de repérer avec précision les blocs de polymorphismes qui doivent être détectés pour établir un génotypage fiable et précis.
En comparant les séquences de ces blocs, provenant de différents gènes d'un même haplotype ou d'un même gène de différents haplotypes, les inventeurs ont pris en considération les enchaînements divergents et élaboré, pour chaque gène, des oligonuclêotides complémentaires de ces enchaînements divergents.The study of the nucleic acid sequences of the molecules defined above has made it possible to pinpoint the blocks of polymorphisms which must be detected in order to establish a reliable and precise genotyping. By comparing the sequences of these blocks, originating from different genes of the same haplotype or from the same gene of different haplotypes, the inventors took into account the divergent sequences and developed, for each gene, oligonucleotides complementary to these divergent sequences. .
On dispose ainsi d'amorces spécifiques et discriminantes vis-à-vis d'un gène donné du système B ou du système Rfp-Y.There are thus specific primers which discriminate against a given gene of the B system or of the Rfp-Y system.
L'invention vise tout spécialement les molécules d' oligonuclêotides correspondant à ces enchaînements et comprenant une partie de la région polymorphe des systèmes du CMH du poulet ou autres oiseaux d'élevage.The invention relates especially to the molecules of oligonucleotides corresponding to these sequences and comprising a part of the polymorphic region of the MHC systems of chicken or other farmed birds.
On rappelle que la région polymorphe peut être dans le gène ou dans une région apparentée telle que les régions microsatellitaires ou celle du promoteur.It is recalled that the polymorphic region may be in the gene or in a related region such as the microsatellite regions or that of the promoter.
Selon un mode de réalisation de 1 ' invention, les polymorphismes sont liés à la fonction des systèmes du CMH. Il s' agit ainsi avantageusement de molécules correspondant à une partie d'un exon. On citera à titre d'exemple des molécules correspondant à l'exon 2 (domaine α 1) des gènes YF du poulet. Un couple d'amorces approprié est constitué par :According to an embodiment of the invention, the polymorphisms are linked to the function of the MHC systems. It is thus advantageously molecules corresponding to a part of an exon. By way of example, mention will be made of molecules corresponding to exon 2 (domain α 1) of the chicken's YF genes. A suitable pair of primers consists of:
Y-F VI α 1 : GGCCCCGGGATGCCGCGGTTC Y-F VI α 1, R : ATCCGCTCACCGCCCTGG
Selon un autre mode de réalisation de l'invention, les molécules oligonucléotidiques correspondent à une partie d'une région polymorphe qui n'est pas liée à la fonction des systèmes du CMH. Des régions préférées de ce type sont des microsatellites.YF VI α 1: GGCCCCGGGATGCCGCGGTTC YF VI α 1, R: ATCCGCTCACCGCCCTGG According to another embodiment of the invention, the oligonucleotide molecules correspond to a part of a polymorphic region which is not linked to the function of the MHC systems. Preferred regions of this type are microsatellites.
En considérant par exemple, le gène B-FI, des molécules d'oligonuclêotides utilisables pour constituer des couples d'amorces correspondent aux enchaînements suivants : B-FI : 5' CCA GCA GTC ACT GCA CAT AT 3'By considering, for example, the B-FI gene, oligonucleotide molecules which can be used to form primer pairs correspond to the following sequences: B-FI: 5 'CCA GCA GTC ACT GCA CAT AT 3'
B-FI, R : 5' AGG TGG AGT GCG CAA AGT T 3', et 12.1 : 5 ' ACA CGC AGC AGA ACT TGG TAA 3 ' 12.1 R : 5 ' GGA AGG AAG ACC TTG GAA 3 'B-FI, R: 5 'AGG TGG AGT GCG CAA AGT T 3', and 12.1: 5 'ACA CGC AGC AGA ACT TGG TAA 3' 12.1 R: 5 'GGA AGG AAG ACC TTG GAA 3'
Avec les molécules oligonucléotidiques définies ci-dessus et celles élaborées à partir de gènes connus, mais selon la démarche de l'invention, on dispose de jeux d'amorces hautement spécifiques, permettant de déterminer avec précision l' haplotype de l'animal à étudier et de détecter s'il est résistant au développement de tumeurs viro-induites, ou au contraire susceptible d'être affecté.With the oligonucleotide molecules defined above and those developed from known genes, but according to the approach of the invention, highly specific sets of primers are available, making it possible to precisely determine the haplotype of the animal to be studied and to detect whether it is resistant to the development of viral-induced tumors, or on the contrary capable of being affected.
L'invention vise donc également une méthode de génotypage d'oiseaux d'élevage et notamment du poulet.The invention therefore also relates to a method of genotyping farmed birds and in particular chicken.
Cette méthode est caractérisée en ce qu'elle comprend l'amplification d'un échantillon d'acide nucléique provenant de l'animal à étudier à l'aide d'un ou de plusieurs couples d'amorces capables de s'hybrider spécifiquement avec l'acide nucléique d'une région polymorphe des systèmes Rfp-Y ou B du CMH desdits oiseaux,
etThis method is characterized in that it comprises the amplification of a sample of nucleic acid originating from the animal to be studied using one or more pairs of primers capable of hybridizing specifically with the nucleic acid of a polymorphic region of the Rfp-Y or B systems of the MHC of said birds, and
- la détection des produits de PCR obtenus.- detection of the PCR products obtained.
Une simple comparaison des résultats obtenus avec un référentiel établi au préalable permet de déterminer rapidement l' haplotype de l'animal.A simple comparison of the results obtained with a benchmark established beforehand allows the haplotype of the animal to be quickly determined.
L'échantillon d'acide nucléique est constitué en particulier par de l'ADN génomique extrait de matériel biologique de l'animal à étudier ou par ce matériel même, en particulier par du sang de l'animal. Il peut s'agir en variante d'ADNc, d'ARN ou encore de PNA (polypeptides nucleic acids) .The nucleic acid sample consists in particular of genomic DNA extracted from biological material of the animal to be studied or by this material itself, in particular from the blood of the animal. It may alternatively be cDNA, RNA or even PNA (polypeptides nucleic acids).
Les amorces sont élaborées à partir des molécules oligonucléotidiques définies ci-dessus et, d'une manière générale, de tout gène (et région apparentée) codant pour une protéine impliquée dans le contrôle de la résistance ou de la susceptibilité aux tumeurs viro-induites chez les oiseaux d'élevage et notamment de poulet, en particulier les gènes B-L de classe II, 17.5, 12.3 et B-FIV de classe I.The primers are produced from the oligonucleotide molecules defined above and, in general, from any gene (and related region) coding for a protein involved in the control of the resistance or the susceptibility to viral-induced tumors in farmed birds and in particular chicken, in particular the BL genes of class II, 17.5, 12.3 and B-FIV of class I.
Il s'agit par exemple d'amorces de régions microsatellitaires permettant de détecter des haplotypes du complexe B, telles que celles élaborées à partir du gène B-FI, et évoquées ci-dessus, ou d'amorces permettant de détecter des haplotypes du système RFp-Y, et élaborées à partir du gène 17.5, comme le couple :These are, for example, primers of microsatellite regions making it possible to detect haplotypes of the B complex, such as those produced from the B-FI gene, and mentioned above, or primers making it possible to detect haplotypes of the system. RFp-Y, and developed from the 17.5 gene, like the couple:
17.52 : CAG GAT CTG CAC TGG CCA ATA17.52: CAG GAT CTG CAC TGG CCA ATA
17.5, RI : GAA TGG CGG TGC TTC CGT GCC TGG17.5, RI: GAA TGG CGG TGC TTC CGT GCC TGG
La détection des produits de PCR est effectuée selon les techniques classiques. Ces techniques
comprennent le séquençage, l 'électrophorèse, les hybridations avec analyse SSOP ou SSCP.The detection of PCR products is carried out according to conventional techniques. These techniques include sequencing, electrophoresis, hybridizations with SSOP or SSCP analysis.
Cette technique sera avantageusement choisie selon la nature du polymorphisme impliqué. Ainsi, dans le cas de polymorphisme de type microsatellite, on détectera avec avantage les produits de PCR selon leur taille en ayant recours aux techniques d' électrophorèse.This technique will advantageously be chosen according to the nature of the polymorphism involved. Thus, in the case of microsatellite type polymorphism, PCR products will be advantageously detected according to their size by using electrophoresis techniques.
Lorsque le polymorphisme ne concerne que quelques nucleotides, voire un seul nucleotide, on aura plus spécialement recours, aux fins de différenciation des haplotypes de produits de PCR, aux techniques d'hybridation (analyse sur membrane à l'aide de sondes spécifiques des séquences d' haplotypes, SSOP ou Séquence Spécifie Oligonucleotide Probe) , de migration différentielle des échantillons dénaturés (SSCP ou Single Strand Conformational Polymorphism) , ou de séquençage . De manière générale, cette dernière technique est préférée compte tenu de la simplicité de sa réalisation.When the polymorphism concerns only a few nucleotides, or even a single nucleotide, hybridization techniques will be used more specifically for the purpose of differentiating haplotypes of PCR products (analysis on a membrane using probes specific for 'haplotypes, SSOP or Sequence Specifies Oligonucleotide Probe), differential migration of denatured samples (SSCP or Single Strand Conformational Polymorphism), or sequencing. In general, the latter technique is preferred given the simplicity of its implementation.
L'invention fournit ainsi une technique simple et rapide d'établissement du profil génétique d'un grand nombre d'animaux à étudier, ce qui permet de déterminer les haplotypes et de sélectionner ceux d'intérêt en vue d'un élevage.The invention thus provides a simple and rapid technique for establishing the genetic profile of a large number of animals to be studied, which makes it possible to determine the haplotypes and to select those of interest with a view to breeding.
De plus, chaque type de gène pouvant être discriminé en utilisant des amorces présentant la spécificité requise et son appartenance au système B ouIn addition, each type of gene that can be discriminated using primers with the required specificity and its belonging to system B or
Rfp-Y pouvant être établie, il est possible d'effectuer des études fondamentales plus complètes.
L'invention vise également un coffret ou trousse pour détecter le génotype du poulet ou autre oiseau d'élevage selon la méthode définie ci-dessus.Since Rfp-Y can be established, it is possible to carry out more comprehensive basic studies. The invention also relates to a box or kit for detecting the genotype of the chicken or other farmed bird according to the method defined above.
Ces coffrets ou trousses sont caractérisés en ce qu'ils comportent les réactifs nécessaires pour la réalisation d'au moins une PCR et du test de révélation.These boxes or kits are characterized in that they contain the reagents necessary for carrying out at least one PCR and the revelation test.
En particulier, ils comportent les amorces pour la PCR, un témoin positif de la réaction, ainsi qu'une notice d'utilisation.In particular, they include the primers for the PCR, a positive control for the reaction, as well as instructions for use.
Les amorces se présentent sous forme lyophilisée ou en solution ou, selon le mode de détection, sur un support. Le support peut être, de manière classique, une plaque multipuits ou se présenter sous forme de puces à ADN.The primers are in lyophilized form or in solution or, depending on the method of detection, on a support. The support can be, in a conventional manner, a multiwell plate or be in the form of DNA chips.
L'invention vise en outre un système expérimental qui permet d'étudier la résistance au développement tumoral chez le poulet .The invention further relates to an experimental system which makes it possible to study the resistance to tumor development in chicken.
Il s'agit de lignées d'animaux qui ont été triées génétiquement sur leurs caractéristiques du CMH. En fonction de ces caractéristiques, les lignées sont soit résistantes, soit sensibles vis-à-vis des tumeurs induites par des virus, comme le virus de la maladie de Marek. Cette sélection génétique, qui s'est dans un premier temps effectuée sur des critères serologiques, a été ensuite poursuivie sur la base de 1 ' étude du polymorphisme des gènes du CMH. Il s'agit d'un matériel génétique qui est parfaitement défini d'un point moléculaire, et constitue un outil précieux pour l'étude du polymorphisme des séquences de type microsatellite. Ce
matériel, ainsi que le produit du croisement entre certaines des lignées entre elles, a été utilisé pour déterminer les séquences microsatellites du CMH qui sont polymorphes et pour évaluer si ce polymorphisme peut être corrélé avec les données de typage déjà disponibles pour ces lignées.These are animal lines that have been genetically sorted on their MHC characteristics. Depending on these characteristics, the lines are either resistant or susceptible to tumors induced by viruses, such as Marek's disease virus. This genetic selection, which was initially carried out on serological criteria, was then continued on the basis of the study of the polymorphism of the MHC genes. It is a genetic material which is perfectly defined from a molecular point, and constitutes a precious tool for the study of polymorphism of microsatellite type sequences. This The material, as well as the product of the crossing between some of the lines between them, was used to determine the microsatellite sequences of the MHC which are polymorphic and to assess whether this polymorphism can be correlated with the typing data already available for these lines.
D'autres caractéristiques et avantages de l'invention sont exposés dans les exemples qui suivent, dans lesquels il est fait référence à la figure 9 représentant une photo d' électrophorèse de produits de PCR illustrant le test de génotypage de l'invention. On rappelle que les figures 1 à 8, déjà évoquées ci-dessus, illustrent les séquences de gènes selon l'invention.Other characteristics and advantages of the invention are set out in the examples which follow, in which reference is made to FIG. 9 representing a photo of electrophoresis of PCR products illustrating the genotyping test of the invention. It will be recalled that FIGS. 1 to 8, already mentioned above, illustrate the gene sequences according to the invention.
Exemple :Example:
Etude d' haplotypes Rfp-Y du poulet à l'aide d'amorces microsatellitaires.Study of Rfp-Y haplotypes of chicken using microsatellite primers.
amplification avec le Kit Expand™ High Fidelity PCR Systemamplification with the High Fidelity PCR System Expand ™ Kit
. Avec les amorces 17.5 Rl/17.52. With the primers 17.5 Rl / 17.52
ADN génomique : 1 μg Oligos prendre : 0,3 μM dNTP : 8 μl qsp H20 50 μl On ajoute 50 μl de Mix 2 en mélangeant,Genomic DNA: 1 μg Oligos take: 0.3 μM dNTP: 8 μl qs H 2 0 50 μl 50 μl of Mix 2 is added by mixing,
Mix 2 : 0,75 μl d'enzymeMix 2: 0.75 μl of enzyme
10 μl TP10X avec MgCl2 qsp H20 50 μl
Programme d'amplification :10 μl TP10X with MgCl 2 qs H 2 0 50 μl Amplification program:
30 Cycles30 Cycles
94°C 94°C 65°C 72°C 4°C 2' 30' ' l' l'94 ° C 94 ° C 65 ° C 72 ° C 4 ° C 2 '30' 'l' l '
. Avec B-FI/B-FI, R :. With B-FI / B-FI, R:
ADN génomique : 1 μgGenomic DNA: 1 μg
Oligos prendre : 0,3 μM dNTP : 8 μl qsp H20 50 μl et ajouter 50 μl de Mix 2 en mélangeant.Oligos take: 0.3 μM dNTP: 8 μl qs H 2 0 50 μl and add 50 μl of Mix 2 by mixing.
Programme d'amplification :Amplification program:
30 Cycles30 Cycles
94°C 94°C 60°C 72°C 4°C 2' 30' ' l' l'94 ° C 94 ° C 60 ° C 72 ° C 4 ° C 2 '30' 'l' l '
révélation par électrophorèse sur gel d ' agarose ou par séquençage .revelation by agarose gel electrophoresis or by sequencing.
Le test a été appliqué à 9 haplotypes de poulet, sélectionnés serologiquement pour le complexe B.The test was applied to 9 chicken haplotypes, serologically selected for complex B.
Il s'agit des haplotypes B4, B5, B7, B12, B13, B14, B15, B21 et d'un haplotype inconnu BX.These are haplotypes B4, B5, B7, B12, B13, B14, B15, B21 and an unknown haplotype BX.
Plusieurs individus d'un même type ont été étudiés pour B12 (6 individus) , B13 (3 individus) , B14 (4
individus) , B21 (4 individus) et un seul individu pour les autres haplotypes .Several individuals of the same type have been studied for B12 (6 individuals), B13 (3 individuals), B14 (4 individuals), B21 (4 individuals) and a single individual for the other haplotypes.
La figure 9 donne une photo d' électrophorèse sur gel d' agarose à 1 % des produits de PCR obtenus à l'issue de l'étape d'amplification.FIG. 9 gives a photo of electrophoresis on agarose gel at 1% of the PCR products obtained at the end of the amplification step.
Les pistes 1 et 27 correspondent aux marqueurs de taille et les pistes (2 à 25) aux produits de PCR des haplotypes suivants : piste 2 : B4 ; piste 4 : B5 ; piste 5 : B7 ; pistes 6 à 11 : B12 ; pistes 12, 13, 14 : B13 ; pistes 15, 16, 17, 18 : B14 ; piste 19 : B15 ; pistes 20, 21, 23, 24 ; B21 ; piste 25 : BX (absence de détection pour les pistes 3 et 22) . L'examen de cette figure montre que les individus qui ont l'haplotype B12 donnent une même bande et sont donc bien homogènes. La même observation s'applique aux individus B14. En revanche, avec B21, on constate que les profils sont différents, ce qui démontre l'inefficacité de l'approche sérologique. Compte-tenu de la position de la bande de BX, on détermine qu'il s'agit d'un haplotype B4.Lanes 1 and 27 correspond to the size markers and lanes (2 to 25) to the PCR products of the following haplotypes: lane 2: B4; lane 4: B5; lane 5: B7; tracks 6 to 11: B12; tracks 12, 13, 14: B13; tracks 15, 16, 17, 18: B14; lane 19: B15; tracks 20, 21, 23, 24; B21; track 25: BX (no detection for tracks 3 and 22). Examination of this figure shows that individuals who have the B12 haplotype give the same band and are therefore very homogeneous. The same observation applies to individuals B14. On the other hand, with B21, we see that the profiles are different, which demonstrates the ineffectiveness of the serological approach. Given the position of the BX band, it is determined that it is a B4 haplotype.
L'application pratique de cette méthode revient à soumettre les individus naturellement résistants au protocole décrit ci-dessus en prenant en compte les deux systèmes Rfp-Y et B du CMH et à ne sélectionner parmi des animaux à tester que ceux dont le profil correspond à celui des animaux résistants.The practical application of this method amounts to subjecting individuals naturally resistant to the protocol described above taking into account the two Rfp-Y and B systems of the MHC and to select from animals to be tested only those whose profile corresponds to that of resistant animals.
L'invention fournit ainsi les moyens de vérifier l'homogénéité des animaux et d'effectuer des sélections rigoureuses en prenant en compte chaque système du CMH, et dans ces systèmes les gènes recherchés .
The invention thus provides the means to verify the homogeneity of the animals and to carry out rigorous selections by taking into account each system of the MHC, and in these systems the genes sought.
Claims
REVENDICATIONS
1/ Molécules d'acides nucléiques isolées de leur environnement naturel, de gènes codant pour des protéines impliquées dans le contrôle de la résistance ou de la susceptibilité au développement de tumeurs chez le poulet, telles que celles de la maladie de Marek, et de régions apparentées auxdits gènes caractérisées en ce qu'elles présentent les séquences d'acides nucléiques de gènes du système B ou du système Rfp-Y, correspondant au complexe majeur d'histocompatibilité des oiseaux d'élevage à l'exception des séquences des gènes de classe II B-L, du gène 17.5, du gène 12.3 et du gène B-FIV de classe I, ou sont capables de s'apparier avec l'un des brins d'un gène capable de coder pour une protéine telle que définie ci-dessus dans des conditions faiblement stringentes .1 / Molecules of nucleic acids isolated from their natural environment, from genes coding for proteins involved in the control of the resistance or susceptibility to the development of tumors in chicken, such as those of Marek's disease, and of regions related to said genes characterized in that they present the nucleic acid sequences of genes of the B system or of the Rfp-Y system, corresponding to the major histocompatibility complex of farmed birds with the exception of the sequences of the class genes II BL, of the gene 17.5, of the gene 12.3 and of the gene B-IVF of class I, or are capable of pairing with one of the strands of a gene capable of coding for a protein as defined above in weakly stringent conditions.
2/ Molécules d'acides nucléiques selon la revendication 1, caractérisées en ce qu'elles répondent à l'un des enchaînements suivants :2 / Nucleic acid molecules according to claim 1, characterized in that they correspond to one of the following sequences:
. enchaînement du système Rfp-Y. Rfp-Y system chaining
B-FV (figure 1), B-FVI (figure 2) ; . enchaînement du système B,B-FV (Figure 1), B-FVI (Figure 2); . sequence of system B,
8.4 génomique (figure 3) ; B-FI (figure 4) ; C121 (figure 5), DM (figure 6), TAPI (du début de l'exon 2 à l'extrémité 3') (figure 7), et TAP2G (figure 8).8.4 genomics (Figure 3); B-FI (Figure 4); C121 (Figure 5), DM (Figure 6), TAPI (from the start of exon 2 to the 3 'end) (Figure 7), and TAP2G (Figure 8).
3/ Molécules d'acides nucléiques selon la revendication 1 ou 2, caractérisées en ce qu'elles correspondent à une partie des séquences définies dans les revendications 1 ou 2, cette partie étant spécifique
et discriminante pour un gène donné des systèmes B et Rfp-Y.3 / Nucleic acid molecules according to claim 1 or 2, characterized in that they correspond to part of the sequences defined in claims 1 or 2, this part being specific and discriminating for a given gene from the B and Rfp-Y systems.
4/ Molécules d'acides nucléiques selon la revendication 3, caractérisées en ce qu'il s'agit de molécules d' oligonuclêotides correspondant à une partie de région polymorphe des systèmes du complexe majeur d'histocompatibilité du poulet.4 / Nucleic acid molecules according to claim 3, characterized in that they are oligonucleotide molecules corresponding to a part of the polymorphic region of the systems of the major histocompatibility complex of chicken.
5/ Molécules d'acides nucléiques selon la revendication 4, caractérisées en ce qu'il s'agit de molécules d' oligonuclêotides correspondant à une partie d ' exon .5 / Nucleic acid molecules according to claim 4, characterized in that they are oligonucleotide molecules corresponding to a part of exon.
6/ Molécules d'acides nucléiques selon la revendication 4, caractérisées en ce qu'il s'agit de molécules d' oligonuclêotides correspondant à une partie de région polymorphe qui n'est pas liée à la fonction des systèmes du CMH, telle que les régions microsatellitaires.6 / Nucleic acid molecules according to claim 4, characterized in that they are oligonucleotide molecules corresponding to a part of polymorphic region which is not linked to the function of MHC systems, such as microsatellite regions.
7/ Méthode de génotypage d'oiseaux d'élevage et notamment du poulet, caractérisée en ce qu'elle comprend7 / Method of genotyping farmed birds and in particular chicken, characterized in that it comprises
- l'amplification d'un échantillon d'acide nucléique provenant de l'animal à étudier à l'aide d'un ou de plusieurs couples d'amorces capables de s'hybrider spécifiquement avec l'acide nucléique d'une région polymorphe des systèmes Rfp-Y ou B du CMH desdits oiseaux, et- amplification of a nucleic acid sample from the animal to be studied using one or more pairs of primers capable of specifically hybridizing with the nucleic acid of a polymorphic region of the MHC Rfp-Y or B systems of said birds, and
- la détection des produits de PCR obtenus.
8/ Méthode selon la revendication 7, caractérisée en ce que les amorces sont élaborées à partir des molécules selon l'une quelconque des revendications 3 à 6, et de tout gène (et région apparentée) codant pour une protéine impliquée dans le contrôle de la résistance ou de la susceptibilité aux tumeurs viro-induites chez les oiseaux d'élevage et notamment de poulet, particulièrement les gènes de classe II B-L, 17.5, 12.3 et B-FIV.- detection of the PCR products obtained. 8 / Method according to claim 7, characterized in that the primers are produced from the molecules according to any one of claims 3 to 6, and from any gene (and related region) coding for a protein involved in the control of resistance or susceptibility to viral-induced tumors in farmed birds, especially chicken, particularly class II genes BL, 17.5, 12.3 and B-FIV.
9/ Méthode selon la revendication 7 ou 8, caractérisée en ce que la détection des produits de PCR est effectuée par séquençage.9 / Method according to claim 7 or 8, characterized in that the detection of PCR products is carried out by sequencing.
10/ Coffret ou trousse pour le génotypage d'oiseaux d'élevages et notamment du poulet, caractérisé en ce qu'ils comportent les réactifs nécessaires pour la réalisation d'au moins une PCR et du test de révélation, selon la méthode de la revendication 8 ou 9, en particulier les amorces élaborées à partir des molécules d'acides nucléiques selon l'une quelconque des revendications 3 à 6.
10 / Box or kit for the genotyping of farmed birds and in particular chicken, characterized in that they contain the reagents necessary for carrying out at least one PCR and of the revelation test, according to the method of claim 8 or 9, in particular the primers produced from the nucleic acid molecules according to any one of claims 3 to 6.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04011368A EP1566450A3 (en) | 1997-11-21 | 1998-11-23 | Reagent and method for detecting the gene 17.5 linked to the MHC of breeding birds |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9714669 | 1997-11-21 | ||
FR9714669A FR2771422B1 (en) | 1997-11-21 | 1997-11-21 | REAGENTS AND METHODS FOR THE DETECTION OF GENES RELATED TO THE MAJOR COMPLEX OF HISTOCOMPATIBILITY OF BREEDING BIRDS, SUCH AS CHICKEN |
PCT/FR1998/002501 WO1999027132A1 (en) | 1997-11-21 | 1998-11-23 | Reagents and methods for detecting genes related to major histocompatibility complex of domestic fowl, such as chicken |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04011368A Division EP1566450A3 (en) | 1997-11-21 | 1998-11-23 | Reagent and method for detecting the gene 17.5 linked to the MHC of breeding birds |
EP04011368.0 Division-Into | 2004-05-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1032702A1 true EP1032702A1 (en) | 2000-09-06 |
Family
ID=9513663
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98955723A Ceased EP1032702A1 (en) | 1997-11-21 | 1998-11-23 | Reagents and methods for detecting genes related to major histocompatibility complex of domestic fowl, such as chicken |
EP04011368A Withdrawn EP1566450A3 (en) | 1997-11-21 | 1998-11-23 | Reagent and method for detecting the gene 17.5 linked to the MHC of breeding birds |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04011368A Withdrawn EP1566450A3 (en) | 1997-11-21 | 1998-11-23 | Reagent and method for detecting the gene 17.5 linked to the MHC of breeding birds |
Country Status (4)
Country | Link |
---|---|
US (1) | US20040170952A1 (en) |
EP (2) | EP1032702A1 (en) |
FR (1) | FR2771422B1 (en) |
WO (1) | WO1999027132A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6667164B1 (en) * | 1996-12-27 | 2003-12-23 | The Board Of Trustees For Northern Illinois University | Method for determining the MHC genotype of chickens |
US5944652A (en) * | 1996-12-27 | 1999-08-31 | City Of Hope | Method for breeding chickens |
US6696253B2 (en) | 1996-12-27 | 2004-02-24 | City Of Hope | Method for determining the MHC genotype of chickens |
WO2001094615A2 (en) * | 2000-06-02 | 2001-12-13 | City Of Hope | Method for breeding and genotyping chickens and probes therefor |
EP1575518A4 (en) | 2002-10-10 | 2007-08-22 | Wyeth Corp | Compositions, organisms and methodologies employing a novel human kinase |
US7208306B2 (en) | 2002-10-24 | 2007-04-24 | Wyeth | Compositions employing a novel human protein phosphatase |
US7611839B2 (en) | 2002-11-21 | 2009-11-03 | Wyeth | Methods for diagnosing RCC and other solid tumors |
US7297525B2 (en) | 2002-11-27 | 2007-11-20 | Wyeth | Composition employing a novel human kinase |
CN116516022A (en) * | 2023-05-30 | 2023-08-01 | 江苏省家禽科学研究所 | Molecular biological identification method and application of pure-bred Dongxiang green-shell layer chicken |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5547835A (en) * | 1993-01-07 | 1996-08-20 | Sequenom, Inc. | DNA sequencing by mass spectrometry |
-
1997
- 1997-11-21 FR FR9714669A patent/FR2771422B1/en not_active Expired - Fee Related
-
1998
- 1998-11-23 WO PCT/FR1998/002501 patent/WO1999027132A1/en not_active Application Discontinuation
- 1998-11-23 EP EP98955723A patent/EP1032702A1/en not_active Ceased
- 1998-11-23 EP EP04011368A patent/EP1566450A3/en not_active Withdrawn
-
2002
- 2002-01-14 US US10/043,160 patent/US20040170952A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO9927132A1 * |
Also Published As
Publication number | Publication date |
---|---|
FR2771422B1 (en) | 2001-07-27 |
EP1566450A3 (en) | 2006-06-07 |
US20040170952A1 (en) | 2004-09-02 |
EP1566450A2 (en) | 2005-08-24 |
WO1999027132A1 (en) | 1999-06-03 |
FR2771422A1 (en) | 1999-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2239896C (en) | Method for evaluation of polymorphic genetic sequences, and the use thereof in identification of hla types | |
Babik | Methods for MHC genotyping in non‐model vertebrates | |
EP0412883B1 (en) | Fast method for detection and/or identification of a single base in a nucleic acid sequence and its applications | |
US20190002979A1 (en) | Haplotyping of hla loci with ultra-deep shotgun sequencing | |
EP1633884B1 (en) | Identification of clonal cells by repeats in (eg.) t-cell receptor v/d/j genes | |
JP2760553B2 (en) | Mutation detection by priming competitive oligonucleotides | |
JP2006517385A (en) | Methods and compositions for genotyping | |
JP2013507964A (en) | Method and associated apparatus for single molecule whole genome analysis | |
JP6234463B2 (en) | Nucleic acid multiplex analysis method | |
US20150379195A1 (en) | Software haplotying of hla loci | |
CA2758753A1 (en) | System and method for detection of hla variants | |
US20030190663A1 (en) | Novel assay for nucleic acid analysis | |
JP2013528061A (en) | Nucleic acid counting | |
EP1032702A1 (en) | Reagents and methods for detecting genes related to major histocompatibility complex of domestic fowl, such as chicken | |
EP1285090A1 (en) | Detection of nucleotide sequence variations via the proofreading activity of polymerases | |
Strand et al. | Genotyping of black grouse MHC class II B using reference Strand-Mediated Conformational Analysis (RSCA) | |
US7829278B2 (en) | Polynucleotide barcoding | |
CA2211666A1 (en) | Method for detecting nucleic acid sequence variations | |
WO1997006276A1 (en) | Co-dominant genetic diagnosis test | |
WO2016054135A1 (en) | Next-generation sequencing for phased hla class i antigen recognition domain exons | |
JP2002330755A5 (en) | ||
JP2001512961A (en) | Microsatellite sequences for canine genotyping. | |
JP2003534778A (en) | Universal variable fragment | |
FR2920159A1 (en) | Identifying, analyzing and/or quantifying alleles of polymorphisms in nucleic acid sample, comprises amplifying double strand of nucleic acid sequence, eliminating heteroduplexes, hybridizing products, and determining and comparing signal | |
FR2881756A1 (en) | Genotypic analysis of Labrador dogs, useful for determining the possible coat colors of their puppies, comprises detecting a premature stop mutation in the gene for tyrosinase-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000522 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE DE ES FR GB IT NL |
|
17Q | First examination report despatched |
Effective date: 20030728 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20051125 |